Oda T, Kagimoto T, Aso N, Yamaguchi K, Tomino S, Takatsuki K
Hematol Oncol. 1985 Jul-Sep;3(3):173-7. doi: 10.1002/hon.2900030305.
Adenosine deaminase (ADA) was assayed in plasma from 14 patients with adult T-cell leukemia (ATL) (eight with acute ATL and six with smoldering or chronic ATL), 20 male family members (ten were anti-ATLA antibody positive and the other ten negative), and 25 normal individuals. ADA activity was uniformly higher in plasma from patients with ATL than normal controls. This enzyme activity significantly increased in acute ATL in comparison to smoldering or chronic ATL. In families of ATL patients, no statistical difference in ADA activity between the anti-ATLA antibody-positive group and -negative group could be discerned. The enzyme activity in a patient with acute ATL, after a bone-marrow transplant, rapidly increased as leukemic cells increased in peripheral blood. These findings indicate that the levels of ADA activities in plasma from ATL patients reflect the condition of this disease. Thus, measurement of this enzyme activity offers a further parameter to distinguish subtypes of ATL, and is of prognostic and therapeutic value.
对14例成人T细胞白血病(ATL)患者(8例急性ATL和6例冒烟型或慢性ATL)、20名男性家庭成员(其中10名抗ATLA抗体阳性,另外10名阴性)以及25名正常个体的血浆进行了腺苷脱氨酶(ADA)检测。ATL患者血浆中的ADA活性始终高于正常对照组。与冒烟型或慢性ATL相比,急性ATL患者的这种酶活性显著升高。在ATL患者的家族中,抗ATLA抗体阳性组和阴性组之间的ADA活性无统计学差异。1例急性ATL患者在骨髓移植后,随着外周血中白血病细胞的增加,其酶活性迅速升高。这些发现表明,ATL患者血浆中ADA活性水平反映了该疾病的状况。因此,检测这种酶活性为区分ATL亚型提供了一个额外的参数,具有预后和治疗价值。